Adamo DO - Search Results

1

Cutaneous manifestations of Taxol therapy.

Link CJ Jr, Sarosy GA, Kohn EC, Christian MC, Davis P, Adamo DO, Reed E. Link CJ Jr, et al. Among authors: adamo do. Invest New Drugs. 1995;13(3):261-3. doi: 10.1007/BF00873811. Invest New Drugs. 1995. PMID: 8729957

2

Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer.

Sarosy G, Kohn E, Stone DA, Rothenberg M, Jacob J, Adamo DO, Ognibene FP, Cunnion RE, Reed E. Sarosy G, et al. Among authors: adamo do. J Clin Oncol. 1992 Jul;10(7):1165-70. doi: 10.1200/JCO.1992.10.7.1165. J Clin Oncol. 1992. PMID: 1376773 Clinical Trial.

3

Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.

Kohn EC, Sarosy G, Bicher A, Link C, Christian M, Steinberg SM, Rothenberg M, Adamo DO, Davis P, Ognibene FP, et al. Kohn EC, et al. Among authors: adamo do. J Natl Cancer Inst. 1994 Jan 5;86(1):18-24. doi: 10.1093/jnci/86.1.18. J Natl Cancer Inst. 1994. PMID: 7505830 Clinical Trial.

4

Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapy.

Link CJ Jr, Bicher A, Kohn EC, Christian MC, Davis PA, Adamo DO, Reed E, Sarosy GA. Link CJ Jr, et al. Among authors: adamo do. Blood. 1994 Mar 1;83(5):1188-92. Blood. 1994. PMID: 7509652 Free article. Clinical Trial.

5

Age does not influence taxol dose intensity in recurrent carcinoma of the ovary.

Bicher A, Sarosy G, Kohn E, Adamo DO, Davis P, Jacob J, Chabner BA, Reed E. Bicher A, et al. Among authors: adamo do. Cancer. 1993 Jan 15;71(2 Suppl):594-600. doi: 10.1002/cncr.2820710216. Cancer. 1993. PMID: 7678382 Clinical Trial.

6

The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor.

Bicher A, Kohn E, Sarosy G, Davis P, Adamo DO, Jacob J, Christian M, Reed E. Bicher A, et al. Among authors: adamo do. Anticancer Drugs. 1993 Apr;4(2):141-8. doi: 10.1097/00001813-199304000-00003. Anticancer Drugs. 1993. PMID: 7683933

7

Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer.

Shapiro JD, Rothenberg ML, Sarosy GA, Steinberg SM, Adamo DO, Reed E, Ozols RF, Kohn EC. Shapiro JD, et al. Among authors: adamo do. Cancer. 1998 Nov 1;83(9):1980-8. Cancer. 1998. PMID: 9806657 Clinical Trial.

8

Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma.

Pluda JM, Shay LE, Foli A, Tannenbaum S, Cohen PJ, Goldspiel BR, Adamo D, Cooper MR, Broder S, Yarchoan R. Pluda JM, et al. J Natl Cancer Inst. 1993 Oct 6;85(19):1585-92. doi: 10.1093/jnci/85.19.1585. J Natl Cancer Inst. 1993. PMID: 7692072 Clinical Trial.

9

New drug therapy for patients with HIV. Nursing implications in the administration of 2',3'-dideoxyinosine (ddI).

Shay LE, Thomas RV, Wyvill KM, Adamo DO, Jenkins JF. Shay LE, et al. Among authors: adamo do. Cancer Nurs. 1990 Oct;13(5):269-77. Cancer Nurs. 1990. PMID: 2123127

10

Adjuvant high-dose intravenous immunoglobulin therapy can be easily and safely introduced as an alternative treatment in patients with severe pemphigus vulgaris: a retrospective preliminary study.

Mignogna MD, Leuci S, Fedele S, Ruoppo E, Adamo D, Russo G, Pagliuca R. Mignogna MD, et al. Am J Clin Dermatol. 2008;9(5):323-31. doi: 10.2165/00128071-200809050-00007. Am J Clin Dermatol. 2008. PMID: 18717608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters